BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2015 10:11:00 AM | Browse: 406 | Download: 550
Publication Name World Journal of Gastroenterology
Manuscript ID 17343
Country of Manuscript Source Turkey
Received
2015-03-02 08:22
Peer-Review Started
2015-03-04 17:12
To Make the First Decision
2015-04-13 16:36
Return for Revision
2015-04-16 11:06
Revised
2015-04-21 18:05
Second Decision
2015-06-03 08:06
Accepted by Journal Editor-in-Chief
2015-06-03 17:27
Accepted by Company Editor-in-Chief
2015-06-10 16:29
Articles in Press
2015-06-10 16:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-07-06 14:31
Publish the Manuscript Online
2015-09-18 10:11
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Letter to the Editor
Article Title Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin’s lymphoma
Manuscript Source Unsolicited Manuscript
All Author List Hasan Tahsin Gozdas and Erkan Arpaci
Funding Agency and Grant Number
Corresponding author Dr. Hasan Tahsin Gozdas, Department of Infectious Diseases and Clinical Microbiology, Dr. Münif İslamoğlu Kastamonu State Hospital, 37100 Kastamonu, Turkey. dr.htgozdas@yahoo.com.tr
Keywords Immunochemotherapy; Hepatitis B reactivation; Antiviral prophylaxis; Lamivudine; Entecavir
Core Tip Lamivudine is used for the prevention of hepatitis B virus (HBV) reactivation in patients receiving immunochemotherapy. Following cessation of lamivudine prophylaxis, HBV reactivation can be observed because of insufficient duration of prophylaxis. If HBV DNA is moderately elevated at that moment, prophylaxis may be continued with lamivudine instead of entecavir.
Publish Date 2015-09-18 10:11
Citation Gozdas HT, Arpaci E. Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin’s lymphoma. World J Gastroenterol 2015; 21(35): 10251-10252
Url http://www.wjgnet.com/1007-9327/full/v21/i35/10251.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i35.10251
Full Article (PDF) WJG-21-10251.pdf
Full Article (Word) WJG-21-10251.doc
Manuscript File 17343-Review.doc
Answering Reviewers 17343-Answering reviewers.pdf
Audio Core Tip 17343-Audio core tip.mp3
Copyright License Agreement 17343-Copyright assignment.pdf
Peer-review Report 17343-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 17343-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 17343-Scientific misconduct check.pdf
Scientific Editor Work List 17343-Scientific editor work list.pdf